Cancer Immunotherapy Drug Discovery Outsourcing - Global Strategic Business Report

Global Cancer Immunotherapy Drug Discovery Outsourcing Market to Reach $4 Billion by 2030

The global market for Cancer Immunotherapy Drug Discovery Outsourcing estimated at US$919.7 Million in the year 2022, is projected to reach a revised size of US$4 Billion by 2030, growing at a CAGR of 20.3% over the analysis period 2022-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is projected to record 19.5% CAGR and reach US$1.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunomodulators segment is readjusted to a revised 21.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $250.6 Million, While China is Forecast to Grow at 25.7% CAGR

The Cancer Immunotherapy Drug Discovery Outsourcing market in the U.S. is estimated at US$250.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$963.3 Million by the year 2030 trailing a CAGR of 25.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.7% and 17.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 16.2% CAGR.

Select Competitors (Total 34 Featured) -

• Aquila Biomedical
• BPS Biosciences Inc.
• Celentyx Ltd.
• Covance, Inc.
• Crown Bioscience Inc.
• DiscoverX Corporation
• Explicit Immuno-Oncology
• Explicyte
• Gen script Biotech Corporation
• HD Biosciences Co. Ltd.
• Horizon Discovery Group PLC
• ImmunXperts SA
• Molecular Imaging Inc. (MI Bioresearch Inc.)
• Personalis, Inc.
• Promega Corporation
• STC Biologics

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year